ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: SA-PO185

8-Hydroxy-2-Deoxyguanosine (8-OHdG), a Marker of Oxidative DNA Damage, Is Associated with Mortality Independent of Inflammation in CKD Patients

Session Information

Category: Nutrition, Inflammation, and Metabolism

  • 1401 Nutrition, Inflammation, Metabolism


  • Lu, Dai, Karolinska Institutet, Stockholm, Sweden
  • Qureshi, Abdul Rashid Tony, Karolinska Institutet, Stockholm, Sweden
  • Mukai, Hideyuki, Karolinska Institutet, Stockholm, Sweden
  • Machowska, Anna, Karolinska Institutet, Stockholm, Sweden
  • Heimburger, Olof, Karolinska Institutet, Stockholm, Sweden
  • Barany, Peter F., Karolinska Institutet, Stockholm, Sweden
  • Stenvinkel, Peter, Karolinska Institutet, Stockholm, Sweden
  • Lindholm, Bengt, Karolinska Institutet, Stockholm, Sweden

Oxidative stress and inflammation are two common interlinked features of CKD that associate with poor outcomes. We tested the hypothesis that inflammation modifies the mortality predictive capacity of serum 8-OHdG in CKD patients.


In 376 clinically stable CKD stage 1-5 patients (63% male; median age 57 years) including 53 CKD stage 1-2, 60 CKD stage 3-4 and 263 CKD stage 5 non-dialysis patients, 8-OHdG, and high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF), were measured at recruitment. The effect of inflammatory markers on the association between baseline 8-OHdG and 5-year mortality risk was investigated using multivariable modeling strategies using cut-off levels of each marker as determined by ROC curve analysis.


The crude mortality rate was markedly increased in patients with high 8-OHdG especially when combined with high hsCRP and IL-6 (Figure 1). In multivariable analysis, adjusting for age, sex, comorbidity, calendar year and eGFR, high 8-OHdG associated with increased relative risk ratio of death, 1.15 (1.07-1.25), 1.16 (1.07-1.25) and 1.17 (1.08-1.26) respectively, when adjusted also for hsCRP, IL-6 and TNF-α, respectively (Table 1).


All-cause mortality risk was increased - independent of inflammation - in CKD patients with elevated 8-OHdG.


  • Commercial Support